Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Wanner C, Inzucchi SE, Zinman B, Koitka-Weber A, et al. Consistent Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of Diabetic Kidney Disease Categories - Insights from the EMPA-REG OUTCOME trial. Diabetes Obes Metab 2020 Aug 3. doi: 10.1111/dom.14158.
PMID: 32744354


Privacy Policy